Effect of atrial fibrillation on atrial thrombogenesis in humans: Impact of rate and rhythm

Journal of the American College of Cardiology

Volumn 61, Issue 8, 2013, Pages 852-860

  Lim, Han S ^a   Willoughby, Scott R ^a   Schultz, Carlee ^a   Gan, Cheryl ^a   Alasady, Muayad ^a   Lau, Dennis H ^a   Leong, Darryl P ^a   Brooks, Anthony G ^a   Young, Glenn D ^a   Kistler, Peter M ^b   Kalman, Jonathan M ^c   Worthley, Matthew I ^a   Sanders, Prashanthan ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

atrial fibrillation; atrium; stroke; thrombosis

Indexed keywords

CD40 LIGAND; N(G),N(G) DIMETHYLARGININE; PADGEM PROTEIN; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; ARTICLE; ATRIAL THROMBOGENESIS; BLOOD CLOTTING; BLOOD SAMPLING; CATHETER ABLATION; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMORAL VEIN; FLOW CYTOMETRY; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART LEFT ATRIUM; HEART RIGHT ATRIUM; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINUS RHYTHM; THROMBOCYTE ACTIVATION;

AGED; ANTITHROMBIN III; ARGININE; ATRIAL FIBRILLATION; CATHETER ABLATION; CD40 LIGAND; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART ATRIA; HEART RATE; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PEPTIDE HYDROLASES; PLATELET ACTIVATION; RISK ASSESSMENT; RISK FACTORS; STATISTICS AS TOPIC; STROKE; THROMBOSIS;

EID: 84874516512     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.11.046     Document Type: Article

References (44)

1. P.A. Wolf, R.D. Abbott, W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 1991 983 988
2. T. Watson, E. Shantsila, G.Y.H. Lip Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited Lancet 373 2009 155 166
3. P. Sanders, J.B. Morton, J.G. Morgan Reversal of atrial mechanical stunning after cardioversion of atrial arrhythmias: implications for the mechanisms of tachycardia-mediated atrial cardiomyopathy Circulation 106 2002 1806 1813
4. K. Yamamoto, U. Ikeda, Y. Seino Coagulation activity is increased in the left atrium of patients with mitral stenosis J Am Coll Cardiol 25 1995 107 112
5. S.R. Willoughby, R.L. Roberts-Thomson, H.S. Lim Atrial platelet reactivity in patients with atrial fibrillation Heart Rhythm 7 2010 1178 1183
6. T. Minamino, M. Kitakaze, S. Sanada Increased expression of P-selectin on platelets is a risk factor for silent cerebral infarction in patients with atrial fibrillation: role of nitric oxide Circulation 98 1998 1721 1727
7. H. Cai, Z. Li, A. Goette Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke Circulation 106 2002 2854 2858
8. P. Sanders, J.B. Morton, P.M. Kistler, J.K. Vohra, J.M. Kalman, P.B. Sparks Reversal of atrial mechanical dysfunction after cardioversion of atrial fibrillation: implications for the mechanisms of tachycardia-mediated atrial cardiomyopathy Circulation 108 2003 1976 1984
9. M.K. Stiles, B. John, C.X. Wong Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: characterizing the "second factor." J Am Coll Cardiol 53 2009 1182 1191
10. S. Mondillo, L. Sabatini, E. Agricola Correlation between left atrial size, prothrombotic state and markers of endothelial dysfunction in patients with lone chronic nonrheumatic atrial fibrillation Int J Cardiol 75 2000 227 232
11. A. Goette, A. Ittenson, P. Hoffmanns Increased expression of P-selectin in patients with chronic atrial fibrillation Pacing Clin Electrophysiol 23 2000 1872 1875
12. G.Y. Lip, G.D. Lowe, A. Rumley, F.G. Dunn Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment Br Heart J 73 1995 527 533
13. J.E. Freedman, J. Loscalzo Platelet-monocyte aggregates: bridging thrombosis and inflammation Circulation 105 2002 2130 2132
14. G. Pongratz, M. Brandt-Pohlmann, K.H. Henneke Platelet activation in embolic and preembolic status of patients with nonrheumatic atrial fibrillation Chest 111 1997 929 933
15. J.G. Akar, W. Jeske, D.J. Wilber Acute onset human atrial fibrillation is associated with local cardiac platelet activation and endothelial dysfunction J Am Coll Cardiol 51 2008 1790 1793
16. H. Sohara, S. Amitani, M. Kurose, K. Miyahara Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation J Am Coll Cardiol 29 1997 106 112
17. A. Choudhury, I. Chung, A.D. Blann, G.Y. Lip Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm J Am Coll Cardiol 49 2007 1957 1964
18. P. Ferroni, F.M. Pulcinelli, L. Lenti, P.P. Gazzaniga Is soluble P-selectin determination a more reliable marker of in vivo platelet activation than CD62P flow cytometric analysis? Thromb Haemost 81 1999 472 473
19. E. Atalar, I.C. Haznedaroglu, T. Acil Patients with paroxysmal atrial fibrillation but not paroxysmal supraventricular tachycardia display evidence of platelet activation during arrhythmia Platelets 14 2003 407 411
20. T. Yamashita, A. Sekiguchi, Y.K. Iwasaki Thrombomodulin and tissue factor pathway inhibitor in endocardium of rapidly paced rat atria Circulation 108 2003 2450 2452
21. Y. Nakamura, K. Nakamura, K. Fukushima-Kusano Tissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: possible involvement in intracardiac thrombogenesis Thromb Res 111 2003 137 142
22. I.W. Black, C.N. Chesterman, A.P. Hopkins, L.C. Lee, B.H. Chong, W.F. Walsh Hematologic correlates of left atrial spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation J Am Coll Cardiol 21 1993 451 457
23. U. Schotten, J. Ausma, C. Stellbrink Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation Circulation 103 2001 691 698
24. A. Frustaci, C. Chimenti, F. Bellocci, E. Morgante, M.A. Russo, A. Maseri Histological substrate of atrial biopsies in patients with lone atrial fibrillation Circulation 96 1997 1180 1184
25. M. Fukuchi, J. Watanabe, K. Kumagai Increased von Willebrand factor in the endocardium as a local predisposing factor for thrombogenesis in overloaded human atrial appendage J Am Coll Cardiol 37 2001 1436 1442
26. M.C. Stuhlinger, R.K. Oka, E.E. Graf Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine Circulation 108 2003 933 938
27. J. Stamler, M.E. Mendelsohn, P. Amarante N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor Circ Res 65 1989 789 795
28. A. Goette, M. Hammwohner, A. Bukowska The impact of rapid atrial pacing on ADMA and endothelial NOS Int J Cardiol 154 2012 141 146
29. A. Meinitzer, U. Seelhorst, B. Wellnitz Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study) Clin Chem 53 2007 273 283
30. T.T. Issac, H. Dokainish, N.M. Lakkis Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data J Am Coll Cardiol 50 2007 2021 2028
31. M.K. Chung, D.O. Martin, D. Sprecher C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation Circulation 104 2001 2886 2891
32. M. Rotter, P. Jais, M.C. Vergnes Decline in C-reactive protein after successful ablation of long-lasting persistent atrial fibrillation J Am Coll Cardiol 47 2006 1231 1233
33. C. Heeschen, S. Dimmeler, C.W. Hamm Soluble CD40 ligand in acute coronary syndromes N Engl J Med 348 2003 1104 1111
34. S.X. Anand, J.F. Viles-Gonzalez, J.J. Badimon, E. Cavusoglu, J.D. Marmur Membrane-associated CD40L and sCD40L in atherothrombotic disease Thromb Haemost 90 2003 377 384
35. V. Henn, J.R. Slupsky, M. Grafe CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells Nature 391 1998 591 594
36. S.D. Corley, A.E. Epstein, J.P. DiMarco Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study Circulation 109 2004 1509 1513
37. T.V. Glotzer, E.G. Daoud, D.G. Wyse The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study Circ Arrhythm Electrophysiol 2 2009 474 480
38. J.S. Healey, S.J. Connolly, M.R. Gold Subclinical atrial fibrillation and the risk of stroke N Engl J Med 366 2012 120 129
39. R.A. Grimm, W.J. Stewart, K. Arheart, J.D. Thomas, A.L. Klein Left atrial appendage "stunning" after electrical cardioversion of atrial flutter: an attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events J Am Coll Cardiol 29 1997 582 589
40. W.A. Ghali, B.I. Wasil, R. Brant, D.V. Exner, J. Cornuz Atrial flutter and the risk of thromboembolism: a systematic review and meta-analysis Am J Med 118 2005 101 107
41. R.D. Rosenberg Biochemistry of heparin antithrombin interactions, and the physiologic role of this natural anticoagulant mechanism Am J Med 87 1989 2S 9S
42. K.A. Bauer Laboratory markers of coagulation activation Arch Pathol Lab Med 117 1993 71 77
43. J.T. Kielstein, B. Impraim, S. Simmel Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans Circulation 109 2004 172 177
44. M.L. Marcovecchio, B. Widmer, D.B. Dunger, R.N. Dalton Effect of acute variations of insulin and glucose on plasma concentrations of asymmetric dimethylarginine in young people with type 1 diabetes Clin Sci (Lond) 115 2008 361 369